An ideal antihypertensive drug acts necessarily save and efficaciously, imp
roves patient survival and reduces end-organ damage. For beta-blockers, diu
retics and calcium channel blockers an improved survival of the hypertensiv
e patients has been shown. On the other hand, short-acting calcium channel
blockers as nifedipine may reduce the outcome in patients with coronary hea
rt disease. Therefore, beta-blockers and diuretics may be used as first-lin
e antihypertensive drugs, whereas only long-acting calcium channel blockers
such as amlodipine may be used in patients with coronary heart disease. Si
de effects should be considered when choosing the antihypertensive drug in
patients with additional (e.g. metabolic) diseases.